Peripheral ulcerative keratitis

• Published in: Survey of ophthalmology 2021-11, Vol.66 (6), p.977-998
• Main Authors: Gupta, Yogita, Kishore, Alisha, Kumari, Pooja, Balakrishnan, Neelima, Lomi, Neiwete, Gupta, Noopur, Vanathi, M., Tandon, Radhika
• Format: Article
• Language: English
• Subjects: Autoimmunity; Cornea; Corneal Ulcer - diagnosis; Corneal Ulcer - etiology; Corneal Ulcer - therapy; Humans; Immunosuppressive Agents - therapeutic use; Mooren ulcer; Mooren's ulcer; peripheral keratitis; Peripheral ulcerative keratitis; PUK
• ISSN: 0039-6257; 1879-3304
• DOI: 10.1016/j.survophthal.2021.02.013

•A review on peripheral ulcerative keratitis (PUK) – its current diagnosis and management.•A systematic approach provided to the readers for workup of a case of PUK.•Emphasis on the rational and judicious use of immunosuppressants in PUK. Peripheral ulcerative keratitis (PUK) is an inflammatory condition of the peripheral cornea with hallmark features of epithelial defects and stromal destruction as a result of a complex interplay of factors including host autoimmunity and the peculiar anatomic and physiologic features of the peripheral cornea and environmental factors. PUK may be the result of local or systemic causes and infectious or noninfectious causes. Arriving at a specific etiological diagnosis requires a meticulous clinical workup that may include a battery of laboratory and radiological investigations. Management by a team of internists or rheumatologists and ophthalmologists and judicious use of immunosuppressive agents may yield favorable results minimizing adverse effects. We review current clinical knowledge on the diagnosis and management of PUK.